These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 942902)

  • 1. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contribution to the biochemical treatment of the Parkinson's disease (author's transl)].
    Calatayud Maldonado V
    Rev Esp Otoneurooftalmol Neurocir; 1978; 36(204):33-41. PubMed ID: 741072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of pheochromocytoma with fusaric acid].
    Shimpo S; Sakata K; Kawashimo K; Kanagi R; Omori Y
    Horumon To Rinsho; 1976 Jun; 24(6):571-6. PubMed ID: 986906
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. A pilot study.
    Viukari M; Linnoila M
    Acta Psychiatr Scand; 1977 Jul; 56(1):57-61. PubMed ID: 331875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-course changes in blood pressure, urinary excretion of norepinephrine and dopamine after administration of fusaric acid in a single dose in elderly hypertensive patients.
    Terasawa F; Hidaka H
    Jpn Circ J; 1976 Jul; 40(7):785-91. PubMed ID: 987254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary norepinephrine excretion in elderly hypertensive patients during administration of fusaric acid.
    Terasawa F; Ying LH; Suzuki T; Hidaka H
    Jpn Circ J; 1976 Sep; 40(9):1033-7. PubMed ID: 994315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proceedings: Case of pheochromocytoma].
    Kawahara H; Kuzutani F; Mizuno S
    Jpn Circ J; 1975 Jul; 39(7):871. PubMed ID: 1160060
    [No Abstract]   [Full Text] [Related]  

  • 14. The hypotensive effect of fusaric acid: the results of long-term administration of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Kameyama M
    Jpn Circ J; 1976 Sep; 40(9):1017-23. PubMed ID: 994313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD; Kudrin AN
    Farmakol Toksikol; 1982; 45(2):63-5. PubMed ID: 7075754
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of craving and withdrawal in humans addicted to narcotics or amphetamines by administration of alpha-methyl-para-tyrosine (AMPT) and 5-butylpicolinic acid (fusaric acid) treatment of narcotic and amphetamine addiction in humans: preliminary report.
    Pozuels J
    Cleve Clin Q; 1976; 43(2):89-94. PubMed ID: 1277534
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R
    Pharmazie; 1982 Oct; 37(10):736. PubMed ID: 7178221
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo release of adrenal catecholamines in rats by fusaric acid.
    Racz K; Kuchel O; Buu NT
    Eur J Pharmacol; 1985 Feb; 109(1):1-7. PubMed ID: 3996464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.